机构表示，根据Precedence Statistics的统计与预测，2023年全球脑机接口市场规模约为23.5亿美元，至 2033年将提升至108.9亿美元，对应2023年—2033年CAGR为17%。而国内脑机接口市场规模目前仅为10 亿元左右，预计2040年将超过1200亿元，对应2024年—2040年CAGR为26%。海内外脑机接口技术目前 仍在应用落地的初期，随着技术的不断进步成熟、政策的支持以及临床试验的推进，预计脑机接口市场 规模将很快进入迅速增长的阶段。 脑机接口概念8日盘中再度走高，截至发稿，倍益康涨超15%，盘中创历史新高；三博脑科涨近12%， 创新医疗、际华集团连续两日涨停，爱朋医疗涨近9%亦创出新高。 消息面上，7日，工业和信息化部等七部门印发《关于推动脑机接口产业创新发展的实施意见》。《意 见》提出，到2027年，脑机接口关键技术取得突破，初步建立先进的技术体系、产业体系和标准体系。 电极、芯片和整机产品性能达到国际先进水平，脑机接口产品在工业制造、医疗健康、生活消费等加快 应用。产业规模不断壮大，打造2至3个产业发展集聚区，开拓一批新场景、新模式、新业态。到2030 年，脑机接口产 ...

（更新中） 恒生科技指数盘初跌超1%，中芯国际跌5.3%领跌成分股。 09:33 脑机接口板块开盘表现活跃 创新医疗、际华集团涨停，三博脑科、倍益康、南京熊猫等跟涨。 | 代码 | 名称 | 涨幅号 | | --- | --- | --- | | 002173 | 创新医疗 | +10.02% | | 601718 | 不华集团 | +10.00% | | 870199 | 倍益康 | 49.52% | | 301293 | 三博脑科 | 48.88% | | 600775 | 南京熊猫 | 45.04% | | 300753 | 爱朋医疗 | +4.78% | | 688767 | 博拓生物 | +3.49% | | 300793 | 佳禾智能 | +3.09% | | 688273 | 麦澜德 | +2.82% | | 603610 | 麒盛科技 | +2.73% | 09:25 A股开盘｜三大指数集体低开 创新药题材跌幅靠前 沪指开盘报3634.85点，跌0.13%，深成指开盘报11136.34点，跌0.19%，创业板指开盘报2338.25点，跌 0.2%。PEEK材料、军工、液冷服务器、稀土永磁、创新 ...

Market Overview - The A-share market opened lower with all three major indices declining: Shanghai Composite Index down 0.13%, Shenzhen Component Index down 0.19%, and ChiNext Index down 0.2% [1] Sector Performance - The brain-computer interface sector opened high, with notable gains: Innovation Medical reached the daily limit up, and Sanbo Brain Science increased over 6%. This follows the issuance of implementation opinions by the Ministry of Industry and Information Technology and six other departments to promote the innovative development of the brain-computer interface industry [1] - Gold stocks experienced a broad increase, with Laishen Tongling rising over 3%, and both Zhaojin Mining and Chifeng Jilong Gold increasing over 2%. The New York gold futures initially touched a historical high of $3534.1 per ounce [1] - The medical device sector continued its upward trend from the previous day, with Sino Medical and Shangrong Medical reaching the daily limit up. The 11th batch of centralized procurement work has recently commenced [1] - The military equipment sector opened lower, with Beifang Changlong dropping over 9% and Hengyu Xintong falling over 5% [1]

Group 1 - The brain-computer interface sector opened high, with Innovation Medical (002173) hitting the limit-up price at the opening [1] - Sanbo Brain Science (301293), Jihua Group (601718), Zhongke Information (300678), and Xiangyu Medical also experienced upward movement [1]

证券日报网讯 三博脑科（301293）8月7日在互动平台回答投资者提问时表示，公司与梅奥进行过学术 交流，业务层面暂无合作。 ...

Investment Rating - The industry investment rating is "Positive" (maintained) [3][6] Core Insights - Recent policies from seven departments in China are aimed at stimulating the brain-computer interface (BCI) industry, encouraging commercialization through local incentives and medical insurance integration [2][4] - The overall goal is to achieve breakthroughs in key technologies by 2027, establish advanced technical, industrial, and standard systems, and significantly enhance innovation capabilities by 2030, fostering globally influential leading enterprises [4] - The report suggests actively monitoring companies within the BCI industry chain, including both upstream hardware/software and downstream medical solution providers [2][4] Summary by Sections Investment Suggestions - Companies to watch in the upstream hardware/software sector include: Entropy Technology, iFlytek, Yanshan Technology, Zhongke Information, Dongfang Zhongke, Yingqu Technology, Nanjing Panda, Lihe Science and Technology, BYD Electronics [2] - In the downstream medical solutions sector, notable companies are: Aipeng Medical, Xiangyu Medical, Chengyitong, Ruimaite, Weisi Medical, Innovation Medical, Sanbo Neuroscience [2] Policy and Development Goals - By 2027, the BCI industry aims to achieve key technological breakthroughs, with products reaching international advanced levels and expanding applications in industrial manufacturing, healthcare, and consumer life [4] - By 2030, the goal is to cultivate 2 to 3 globally influential leading enterprises and a number of specialized small and medium-sized enterprises, establishing a competitive industrial ecosystem [4] Technical Advancements - Focus on enhancing brain signal sensing capabilities through innovative materials and processes, developing high-performance, low-power brain-machine chips, and integrating AI into decoding processes [4] - Accelerate the development of high-performance products, including both implantable and non-implantable devices, to improve control precision and response speed [4]

Group 1 - The core viewpoint of the articles highlights the performance and valuation of Sanbo Brain Science, which closed at 54.59 yuan, up 5.12%, with a rolling PE ratio of 102.32, marking a new low in 96 days, and a total market capitalization of 11.245 billion yuan [1] - The average PE ratio for the medical services industry is 46.96, with a median of 57.43, placing Sanbo Brain Science at the 38th position within the industry [1] - As of the first quarter of 2025, only one institution holds shares in Sanbo Brain Science, with a total of 535,900 shares valued at 2.8 million yuan [1] Group 2 - Sanbo Brain Science's main business is clinical medical services, with primary products including medical services, pharmaceuticals, supply chain, and other businesses [1] - The latest performance report for the first quarter of 2025 shows that the company achieved operating revenue of 393 million yuan, a year-on-year increase of 16.78%, and a net profit of 38.3136 million yuan, a year-on-year increase of 14.56%, with a gross profit margin of 26.44% [1] - The PE ratios for Sanbo Brain Science are 102.32 (TTM) and 107.06 (static), with a price-to-book ratio of 4.81 [2]

资金面上看，今日脑机接口概念板块获主力资金净流入4.21亿元，其中，17股获主力资金净流入，6股 主力资金净流入超3000万元，净流入资金居首的是际华集团，今日主力资金净流入3.88亿元，净流入资 金居前的还有创新医疗、汉威科技、三博脑科等，主力资金分别净流入2.26亿元、5017.95万元、 4944.78万元。 截至8月7日收盘，脑机接口概念上涨2.69%，位居概念板块涨幅第2，板块内，27股上涨，际华集团、 创新医疗等涨停，倍益康、翔宇医疗、爱朋医疗等涨幅居前，分别上涨17.75%、11.74%、8.45%。跌幅 居前的有谱尼测试、普利特、均普智能等，分别下跌1.77%、1.75%、1.68%。 今日涨跌幅居前的概念板块 | 概念 | 今日涨跌幅（%） | 概念 | 今日涨跌幅（%） | | --- | --- | --- | --- | | 稀土永磁 | 3.24 | 减肥药 | -1.70 | | 脑机接口 | 2.69 | CRO概念 | -1.66 | | 高压氧舱 | 2.56 | 创新药 | -1.41 | | 太赫兹 | 1.65 | 仿制药一致性评价 | -1.34 | | 血氧仪 | ...

格隆汇8月7日丨三博脑科(301293.SZ)于投资者互动平台表示，公司与梅奥进行过学术交流，业务层面 暂无合作。 ...

格隆汇8月7日丨三博脑科(301293.SZ)于投资者互动平台表示，公司与梅奥进行过学术交流，业务层面 暂无合作。 ...